Pulmonary hypertension in the interstitial lung diseases

Chest

Volumn 87, Issue 5, 1985, Pages 558-560

  Kennedy, J I ^a   Fulmer, J D ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDRALAZINE;

BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; COR PULMONALE; DIAGNOSIS; DRUG THERAPY; ETIOLOGY; GREAT BLOOD VESSEL; HEART; HEMODYNAMICS; HUMAN; INTERSTITIAL LUNG DISEASE; PATHOGENESIS; PERIPHERAL VASCULAR SYSTEM; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY SYSTEM; REVIEW; THERAPY; VASCULITIS; VASOCONSTRICTION;

EID: 0021979099     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.87.5.558     Document Type: Editorial

References (35)

1. Battesti JP Georges R Basset F Saumon G. Chronic cor pulmonale in pulmonary sarcoidosis Thorax 33 1978 76 84
2. Crystal RG Fulmer JD Roberts WC Moss ML Line BR Reynolds HY. Idiopathic pulmonary fibrosis Ann Intern Med 85 1976 769 788
3. Lapp NL Seaton A Kaplan KC Hunsaker MR Morgan WKC. Pulmonary hemodynamics in symptomatic coal miners Am Rev Respir Dis 104 1971 418 426
4. Stack HR Choo-Kang YF Heard BC. The prognosis of cryptogenic fibrosing alveolitis Thorax 27 1972 535 542
5. Fishman AP. Chronic cor pulmonale Am Rev Respir Dis 114 1976 775 794
6. Enson Y Thomas HM III Bosken CH Wood JA Leroy EC Blanc WA Pulmonary hypertension in interstitial lung disease: relation of vascular resistance to abnormal lung structure Tran Assoc Am Physic 88 1975 248 255
7. Fishman AP. Vasomotor regulation of the pulmonary circulation Ann Rev Physiol 42 1980 211 220
8. Bergofsky EH. Humoral control of the pulmonary circulation Ann Rev Physiol 42 1980 221 233
9. Enson Y Giuntini C Lewis ML Morris TQ Ferrer MI Harvey RM. The influence of hydrogen ion concentration and hypoxia on the pulmonary circulation J Clin Invest 43 1964 1146 1162
10. Lee GDJ. Regulation of the pulmonary circulation Br Heart J 33 suppl 1971 15 26
11. Harvey RM Enson Y Ferrer MI. A reconsideration of the origins of pulmonary hypertension Chest 59 1972 82 94
12. Brigham KL Bowers RE Owen PJ. Effects of antihistamines on the lung vascular response to histamine in unanesthetized sheep J Clin Invest 58 1976 391 398
13. Rubin LJ Peter RH. Oral hydralazine therapy for primary pulmonary hypertension N Engl J Med 302 1980 69 73
14. Honey M Cotter L Davies N Denison D. Clinical and haemodynamic effects of diazoxide in primary pulmonary hypertension Thorax 35 1980 269 276
15. Ruskin JN Hutter AM. Primary pulmonary hypertension treated with oral phentolamine Ann Intern Med 90 1979 772 774
16. Niarchos AP Roberts AJ Laragh JH. Effects of the converting enzyme inhibitor (SQ 20881) on the pulmonary circulation in man Am J Med 67 1979 785 792
17. Olivari M-T Levine TB Weir EK Cohn JN. Hemodynamic effects of nifedipine at rest and during exercise in primary pulmonary hypertension Chest 86 1984 14 19
18. Fritts HW Harris P Clauss RH Odell JE Cournand A. The effect of acetylcholine on the human pulmonary circulation under normal and hypoxic conditions J Clin Invest 37 1958 99 110
19. Dresdale DT Michtom RJ Schultz M. Recent studies in primary pulmonary hypertension including pharmacodynamic observations on pulmonary vascular resistance Bull NY Acad Med 30 1954 195 207
20. Hermiller JB Bambach D Thompson MJ Huss P Fontana ME Magorien RD Vasodilators and prostaglandin inhibitors in primary pulmonary hypertension Ann Intern Med 97 1982 480 489
21. Knapp E Gmeiner R. Reduction of pulmonary hypertension by nitroprusside Int J Clin Pharmacol 15 1977 75 80
22. Person B Proctor RJ. Primary pulmonary hypertension Chest 76 1979 601 603
23. Landmark K Refsum AM Simonsen S Storstein O. Verapamil and pulmonary hypertension Acta Med Scand 204 1978 299 302
24. Pearl RG Rosenthal MH Schroeder JS Ashton JPA. Acute hemodynamic effects of nitroglycerin in pulmonary hypertension Ann Intern Med 99 1983 9 13
25. 1 on pulmonary circulation in patients with pulmonary hypertension Br Heart J 40 1978 1397 1401
26. Rozkovec A Stradling J Minty K Shepherd G Oakley CM. Hydralazine in pulmonary hypertension N Engl J Med 307 1982 1214 1316
27. Farber HW Karlinsky JB Falin LJ. Fatal outcome following nifedipine for pulmonary hypertension Chest 4 1983 708 709
28. Packer M Greenberg B Massie B Dash H. Deleterious effects of hydralazine in patients with pulmonary hypertension N Engl J Med 306 1982 1326 1331
29. Tuxen DV Powles ACP Mathur PN Pugsley SO Campbell EJM. Detrimental effects of hydralazine in patients with chronic air-flow obstruction and pulmonary hypertension Am Rev Respir Dis 129 1984 388 396
30. Melot C Hallemans R Naeije R Mols P Lejeune P. Deleterious effect of nifedipine on pulmonary gas exchange in chronic obstructive pulmonary disease Am Rev Respir Dis 130 1984 612 616
31. Rubin LJ. Therapy for pulmonary hypertension and advanced COPD Vasodilators in lung disease: using the new agents wisely. J Respir Dis 4 1983 83 89
32. Lupi-Herrera E Sandoval J Bialostozky D Seoane M Martinez ML Bonetti PF Extrinsic allergic alveolitis caused by pigeon breeding at a high altitude (2,240 meters) Am Rev Respir Dis 124 1981 602 607
33. Stanbrook HS Morris KG McMurtry IF. Prevention and reversal of hypoxic pulmonary hypertension by calcium antagonists Am Rev Respir Dis 130 1984 81 85
34. Keller CA Shepard JW Jr Chun DS Dolan GF Vasquez P Minh VD. Effects of hydralazine on hemodynamics, ventilation, and gas exchange in patients with chronic obstructive pulmonary disease and pulmonary hypertension Am Rev Respir Dis 130 1984 606 611
35. Naeije R Melot C Mols P Hallemans R. Effects of vasodilators on hypoxic pulmonary vasoconstriction in normal man Chest 4 1982 404 410